2/5/2019 8:20:24 AM
Biomerica Reports Regulatory And Clinical Advancements In Development Program For H. Pylori Diagnostic Product
1/15/2019 8:20:59 AM
Biomerica Q2 Net Loss $477,244 Or $0.05 Per Share
11/28/2018 8:21:44 AM
Biomerica Signs 3 Year Agreement With Medline Industries
10/16/2018 8:32:35 AM
Biomerica Q1 Net Loss $452K; Net Sales $1.27 Mln
8/30/2018 8:24:09 AM
Biomerica FY Net Loss $1.47 Mln Vs. Net Loss Of $908,561 Prior Year
8/2/2018 8:24:25 AM
Biomerica Receives Notice Of Allowance For Irritable Bowel Syndrome Test Panel And Methods In Korea
6/25/2018 8:21:45 AM
Biomerica Announces First Patient Enrollment In Clinical Study For New IBS Diagnostic Guided Therapy
4/19/2018 8:19:52 AM
Biomerica Appoints Harry Leider To Strategic Advisory Board
4/17/2018 9:09:46 AM
Biomerica Q3 Sales $1.37 Mln Vs. $1.49 Mln Last Year
3/8/2018 8:22:04 AM
Mexico’s COFEPRIS Approves Biomerica Colorectal Screening Test To Help Identify Early Warning Signs Of Colorectal Cancer
1/16/2018 9:32:01 AM
Biomerica Q2 Sales Up 12.7%
1/10/2018 8:21:28 AM
Chinese FDA Oks Biomerica Colorectal Screening Test To Help Identify Early Warning Signs Of Colorectal Cancer
1/8/2018 8:28:46 AM
Biomerica Signs Agreements To Initiate Clinical Study For IBS Diagnostic Guided Therapy
1/4/2018 12:24:48 PM
B. Riley FBR Starts BIOMERICA INC (BMRA) At Buy With $7.50 Price Target